Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
The prevalence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), increases gradually worldwide in the past decades. IBD is generally associated with the change of the immune system and gut microbiota, and the conventional treatments usually result...
Main Authors: | Shunyu Yao, Zixi Zhao, Weijun Wang, Xiaolu Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2021/8030297 |
Similar Items
-
Unique strain of Bifidobacterium longum and its efficacy in irritable bowel syndrome
by: E. Yu. Plotnikova
Published: (2021-01-01) -
Gene Networks Underlying the Resistance of Bifidobacterium longum to Inflammatory Factors
by: Vladimir A. Veselovsky, et al.
Published: (2020-11-01) -
Colonization and probiotic function of Bifidobacterium longum
by: Chengcheng Zhang, et al.
Published: (2019-02-01) -
Bioaccessible Antioxidants in Milk Fermented by Bifidobacterium longum subsp. longum Strains
by: Mérilie Gagnon, et al.
Published: (2015-01-01) -
Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure
by: Kaicen Wang, et al.
Published: (2020-01-01)